Resverlogix Corp.

Canada


Commandez votre montre hebdomadaire Resverlogix Corp.
Quantité totale PI 57
Rang # Quantité totale PI 24 440
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 317
Symbole boursier
ISIN CA76128M1086
Capitalisation 182M  (CAD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

24 1
11 6
14 0
1
 
Dernier brevet 2023 - Methods for lowering hba1c level...
Premier brevet 2003 - The use of resveratrol to regula...
Dernière marque 2011 - RESVERLOGIX
Première marque 2004 - TGFß SHIELD

Industrie (Classification de Nice)

Derniers inventions, produits et services

2021 Invention Methods for lowering hba1c level with a combination of a bet bromodomain inhibitor and a sodium d...
Invention Methods for improving renal function with a combination of a bet bromodomain inhibitor and a sodi...
Invention Compounds for the prevention and treatment of cardiovascular diseases. The present disclosure re...
Invention Methods of treatment and/or prevention of major adverse cardiovascular events (mace) with a combi...
2020 Invention Anti-inflammatory agents. Disclosed are novel compounds that are useful in regulating the express...
2019 Invention Novel anti-inflammatory agents. Disclosed are methods of regulating interleukin-6 (IL-6) and/or ...
2018 Invention Compositions and therapeutic methods for the treatment of complement-associated diseases. The inv...
2017 Invention Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for prepar...
Invention Compounds for the prevention and treatment of cardiovascular diseases. The present disclosure rel...
Invention Pharmaceutical compositions for substituted quinazolinones. The present disclosure relates to nov...
2014 Invention Compositions and therapeutic methods for accelerated plaque regression. The invention comprises ...
Invention Compositions and therapeutic methods for accelerated plaque regression. The invention comprises m...
2013 Invention Compounds useful in the synthesis of benzamide compounds. The compounds of Formula (I) wherein R1...
Invention Compounds useful in the synthesis of benzamide compounds. Compounds that are useful in the synthe...
2012 Invention Oral immediate release formulations for substituted quinazolinones. The present disclosure relate...
2011 P/S Scientific and medical research and development in respect of therapeutic-based treatments and pr...
2010 Invention Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases. The present ...
Invention Anti-inflammatory agents. Disclosed are methods of regulating interleukin-6 (IL-6) and/or vascula...
Invention Novel anti-inflammatory agents. Disclosed are methods of regulating interleukin-6 (IL-6) and/or v...
Invention Novel anti-inflammatory agents. Disclosed are novel compounds that are useful in regulating the e...
Invention Compounds for the prevention and treatment of cardiovascular disease. Disclosed are novel compoun...
2009 P/S Providing information related to ways of increasing good cholesterol and decreasing the risk of a...
P/S Providing information related to the treatment and understanding of cancer and fibrotic disease v...
Invention Methods of preparing quinazolinone derivatives. The present disclosure relates to methods for pre...
Invention Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases. The pre...
2006 Invention Pharmaceutical compositions for the prevention and treatment of complex diseases and their delive...
2004 Invention Treatment of diseases associated with the egr-1 enhancer element. Compounds and methods are prov...
P/S Informational materials namely brochures, information sheets, fact sheets, pamphlets and manuals ...
P/S Informational materials to assist in the treatment and understanding of cancer, namely, brochures...